For the millions who rely on corticosteroids to manage chronic illness, the drugs have always carried a quiet gamble — relief for some, serious harm for others, with little way to know in advance which fate awaited. Researchers at the University of Exeter, drawing on nearly 38,000 participants from the UK Biobank, have now shown that genetic data — including specific variants and polygenic risk scores — can meaningfully sharpen that prediction. The work, presented at the European Society of Human Genetics conference, points toward a future where prescribing decisions are shaped not only by sym
Genetic data could help doctors predict steroid side effects, study suggests
Related Coverage
GPS tracking reveals a northern boobook owl flew nonstop 1,848km from Japan to the Philippines in 36 hours, challenging …
Genetic Literacy Project · Aug 25 CRISPR-edited tomatoes yield 6x more fruit in cold conditions, study findsResearchers used CRISPR gene-editing to create tomato varieties that produce fruit reliably in cold conditions, yielding…
Space · Aug 25 Astronauts Complete ISS Antenna Replacement in Second SpacewalkNASA astronaut Anil Menon and ESA's Sophie Adenot conduct a spacewalk to replace a failed communications antenna on the …
Mental Floss · Aug 25 Test Your Knowledge: 25 Trivia Questions Spanning History and General FactsMental Floss presents 25 trivia questions testing readers' knowledge of August 25 historical events, general August fact…
Bias & Framing
Article presents research on genetic predictors of steroid side effects with neutral, evidence-based framing and minimal bias signals.
Scientific advancement framing - presents research findings as progress toward personalized medicine without sensationalism or advocacy
Geopolitical Impact
Medical research on personalized steroid prescribing has no direct geopolitical implications; this is a domestic healthcare advancement with potential global medical applications.
Economic Lens
Genetic testing integration in steroid prescribing enables personalized medicine, reducing adverse effects and improving treatment efficiency for chronic inflammatory conditions.
Patients gain access to more personalized steroid treatment with reduced side effect risk, potentially lowering out-of-pocket costs for managing complications like osteoporosis and stroke, while improving quality of life for chronic inflammatory condition sufferers.
Healthcare systems may need to integrate genetic testing into standard steroid prescribing protocols, potentially requiring regulatory approval for polygenic risk score tools. Insurance coverage policies for genetic testing in drug prescribing decisions will likely evolve, and clinical guidelines for corticosteroid use may be updated to incorporate genetic risk stratification.